Navigation Links
ev3 Inc. Reports 2008 Fourth Quarter and Full-Year Financial Results and 2009 Guidance
Date:2/24/2009

Fourth Quarter Net Product Sales Increased 22% Over Fourth Quarter 2007

Achieved Fourth Quarter Non-GAAP Adjusted Earnings Per Share of $0.08

Cash and Cash Equivalents Increased by $13.7 Million to $59.7 Million

PLYMOUTH, Minn., Feb. 24 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV), a global endovascular device company, today reported financial results for its fiscal fourth quarter and full-year of 2008 and its financial guidance for 2009. Reconciliations of non-GAAP financial measures used in this release to the most comparable U.S. GAAP measures for the respective periods can be found immediately following the detail of net sales by geography later in this release.

ev3's net sales were $106.1 million in the fourth quarter of 2008, representing a 15% increase over the same quarter of the prior year. Fourth quarter net product sales totaled approximately $105.6 million and increased 22% versus the prior year quarter. Research collaboration revenues were approximately $469 thousand in the fourth quarter of 2008 compared to $6.0 million in the fourth quarter of 2007. By product segment, fourth quarter neurovascular net sales increased by 32%, and peripheral vascular net product sales increased by 18%. On a geographic basis, ev3 U.S. net sales, excluding revenues from the prior Merck research and collaboration agreement, increased approximately 14% over the prior year quarter. International net sales increased 41% over the prior year quarter. Changes in foreign currency exchange rates had a negative impact of approximately $2.7 million on fourth quarter of 2008 net sales compared to the fourth quarter of the prior year.

For the year ended December 31, 2008, ev3's net sales increased 49% to $422.1 million versus $284.2 million for the year ended December 31, 2007. Athere
'/>"/>

SOURCE ev3 Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine news :

1. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
2. Haemacure Reports Third Quarter 2007 Results
3. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
4. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
5. MDS Reports Third Quarter 2007 Results
6. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
7. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
8. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
9. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
10. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
11. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... 04, 2015 , ... The Schmidt National Law Group filed an Essure® lawsuit ... Schmidt National Law Group, a leading firm in mass-tort litigation, has filed a lawsuit ... Essure, Inc., and other Bayer affiliates for injuries alleged to have been caused by ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... Health Products Association (CHPA) joint meeting of its Product, Quality and Manufacturers, Dietary ... waste handling rules constantly evolving in the consumer goods industry, it can be ...
(Date:9/4/2015)... , ... September 04, 2015 , ... “Getting away from ... for couples to explore, revitalize and strengthen their ‘couple-ness,’” says Jean Claude Wietzel, ... at Four Seasons Resort Maui, the island’s only Forbes Five Star resort and Travel ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... the microbiome taking place in Hollywood, Florida October 9-10, 2015 at the Diplomat ... at the 2015 symposium are doctors and researchers at the top of their ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... in comparison to settlements under the Stark physician self-referral law. “Stark Law ... 17 webinar from Atlantic Information Services, Inc. (AIS), will detail which deals are ...
Breaking Medicine News(10 mins):Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2
... A new study released,today found that pending congressional ... medical technologies would likely result,in increased prices and ... study, released today at the National Press Club ... Center and senior fellow at,the American Enterprise Institute, ...
... Sales, Managed Care and Government ... Accounts on national ... company with an 85-year history of innovation and achievement in,diabetes ... president for Diabetes Sales, Managed Care and Government Accounts,effective immediately., ...
... Health Enterprises, LLC,today released notice of the final ... processing all Part A and Part B,fee-for-service Medicare ... TrailBlazer also reiterated the availability of its Jurisdiction ... communicate details of the implementation,to health care providers ...
... is a constant threat to US military personnel ... further risk, as epidemiologists have revealed a significant ... the anti-malarial drug, mefloquine. , Whilst mefloquine ... long-term malaria chemoprophylaxis, research reported in the open ...
... Viola Startzman, M.D. of,Wooster, Ohio is a recipient ... in Volunteerism. Presented by the American Medical Association,(AMA) Foundation, ... to volunteer medical care to those without access to ... award in association with the,Pfizer Medical Humanities Initiative., ...
... Feb. 19 Joyce D. Kirkland Essien,M.D., M.B.A., of ... the,Profession Awards. Presented by the American Medical Association (AMA),Foundation, ... underserved,populations in the U.S. The AMA Foundation presents the ... The award will be presented on Monday, March 31st, ...
Cached Medicine News:Health News:New Report Finds Mandatory Price Disclosure for Med Tech Would Likely Increase Prices 2Health News:Novo Nordisk Consolidates U.S. Diabetes Sales Leadership Under Single Vice President 2Health News:TrailBlazer Announces Final Medicare Administrative Contractor Schedule for Claims Processing in Four States 2Health News:Appropriate medical screening for antimalarials vital to US military personnel 2Health News:AMA Foundation Honors Wooster, Ohio Physician for Volunteerism 2Health News:AMA Foundation Honors Atlanta Physician for Increasing Access to Health Care in the U.S. 2
(Date:9/4/2015)... HILL, N.C. , Sept. 4, 2015 ... and therapeutic areas, and has become a key marketing ... still slow to fully adopt E-sampling as a supplement ... by benchmarking firm, Best Practices, LLC, physician E-sampling has ... most other large chronic areas. While E-sampling has been ...
(Date:9/4/2015)... N.J. , Sept. 4, 2015  Janssen Research ... Food and Drug Administration (FDA) has accepted for ... daratumumab as a treatment for patients with multiple ... inhibitor (PI) and an immunomodulatory agent (IMiD), or ... of therapy, including a PI and an IMiD. ...
(Date:9/4/2015)... Fair Rate Funding, a lawsuit funding firm located in ... in lawsuit filings in connection with the blood thinning drug, ... Philadelphia Court of Common Pleas has risen ... Louisiana multi---district litigation (MDL), located in the ... Louisiana , the filings are also on the rise, ...
Breaking Medicine Technology:Current and Future Trends in Physician E-Sampling Programs for the Pharmaceutical Industry 2U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 2U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 3U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 4U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 5U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 6U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 7Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 2Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 3
... March 31, 2011 Reportlinker.com announces that a ... catalogue: Molecular Diagnostics in ... http://www.reportlinker.com/p0368860/Molecular-Diagnostics-in-Infectious-Disease-Testing.html This TriMark Publications report ... diagnostics market known as molecular diagnostics testing for ...
... 2011 Reportlinker.com announces that a new ... catalogue: Gout Therapeutics Market ... as Krystexxa, Uloric, Adenuric and Colcrys to ... Gout Therapeutics Market to ...
Cached Medicine Technology:Reportlinker Adds Molecular Diagnostics in Infectious Disease Testing 2Reportlinker Adds Molecular Diagnostics in Infectious Disease Testing 3Reportlinker Adds Molecular Diagnostics in Infectious Disease Testing 4Reportlinker Adds Molecular Diagnostics in Infectious Disease Testing 5Reportlinker Adds Molecular Diagnostics in Infectious Disease Testing 6Reportlinker Adds Molecular Diagnostics in Infectious Disease Testing 7Reportlinker Adds Molecular Diagnostics in Infectious Disease Testing 8Reportlinker Adds Molecular Diagnostics in Infectious Disease Testing 9Reportlinker Adds Molecular Diagnostics in Infectious Disease Testing 10Reportlinker Adds Molecular Diagnostics in Infectious Disease Testing 11Reportlinker Adds Molecular Diagnostics in Infectious Disease Testing 12Reportlinker Adds Molecular Diagnostics in Infectious Disease Testing 13Reportlinker Adds Molecular Diagnostics in Infectious Disease Testing 14Reportlinker Adds Molecular Diagnostics in Infectious Disease Testing 15Reportlinker Adds Molecular Diagnostics in Infectious Disease Testing 16Reportlinker Adds Molecular Diagnostics in Infectious Disease Testing 17Reportlinker Adds Molecular Diagnostics in Infectious Disease Testing 18Reportlinker Adds Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market 2Reportlinker Adds Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market 3Reportlinker Adds Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market 4Reportlinker Adds Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market 5Reportlinker Adds Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market 6Reportlinker Adds Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market 7Reportlinker Adds Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market 8Reportlinker Adds Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market 9Reportlinker Adds Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market 10Reportlinker Adds Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market 11Reportlinker Adds Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market 12
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: